United Therapeutics (UTHR) Tops Q1 EPS by 41c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $501.27 --0%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $2.55, $0.41 better than the analyst estimate of $2.14. Revenue for the quarter came in at $327.6 million versus the consensus estimate of $353.5 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- RCM Technologies (RCMT) Tops Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
